About the Authors
- Luca A. Petruccelli
-
Contributed equally to this work with: Luca A. Petruccelli, Daphné Dupéré-Richer
Affiliation Lady Davis Institute for Medical Research, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, Canada
- Daphné Dupéré-Richer
-
Contributed equally to this work with: Luca A. Petruccelli, Daphné Dupéré-Richer
Affiliation Lady Davis Institute for Medical Research, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, Canada
- Filippa Pettersson
-
Affiliation Lady Davis Institute for Medical Research, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, Canada
- Hélène Retrouvey
-
Affiliation Lady Davis Institute for Medical Research, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, Canada
- Sophia Skoulikas
-
Affiliation Lady Davis Institute for Medical Research, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, Canada
- Wilson H. Miller Jr.
-
* E-mail: wmiller@ldi.jgh.mcgill.ca
Affiliation Lady Davis Institute for Medical Research, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, Canada
Competing Interests
This work was financially supported in part by a research grant from Merck. Merck also supplied Vorinostat. This does not affect the authors' ability to adhere to all of PLoS ONE's policies on sharing data and materials with regards to this work.
Author Contributions
Conceived and designed the experiments: LAP DD-R FP WHM. Performed the experiments: LAP DD-R FP HR SS. Analyzed the data: LAP DD-R FP HR SS WHM. Contributed reagents/materials/analysis tools: WHM. Wrote the paper: LAP DD-R FP WHM.